2 completed. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow sodium fusidate: new trials by email Literature Review of sodium fusidate trials Research Report on sodium fusidate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Oral Sodium Fusidate (CEM-102) for the Treatment of Staphylococcal Bone or Joint Infections sodium fusidate - Refractory Bone or Joint Infections | Phase 2 / Phase 3 | Completed | Arrevus Inc. | 30 | 2015-12-01 | 2020-01-30 |
| Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections sodium fusidate, linezolid - Acute Bacterial Skin and Skin Structure Infections | Phase 3 | Completed | Arrevus Inc. | 716 | 2015-11-01 | 2019-04-19 |
Cellulitis (1) · Osteomyelitis (1)
Arrevus Inc. (2)
United States (2) · Puerto Rico (1)
Richard Pushkin, MD (1) · Robert Dobbins, MD, PhD (1)